The U.S. government is accusing OMICS publishing of trademark violation for falsely representing government-run products and employees on the OMICS website and in their promotions. Particularly in question are OMICS claims to be indexed in the National Institute of Health's PubMed and depositing its articles to PubMed Central. This is the first enforcement by the government against a publisher with a history of false claims about its business practices, particularly its claims of adhering to
open access codes of conduct. Read the full article in
Science Insider.